|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Impact of triple antithrombotic therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention in real-world practice显示文摘为在急性冠的症候群(交流) 和经皮的冠的干预(一种总线标准) 以后的口头的 anticoagulation (OAC ) 上的病人的 ObjectiveThe 最佳的 antithrombotic 政体仍然保持辩论。寻求回顾地在真实世界的 setting.MethodsWe 评估 OAC 正 clopidogrel 的功效和安全与或没有阿司匹林的这研究分析了数据从一国际,在 2003 和 2014 之间的多中心登记(n = 15,401 ) 。有在一种总线标准以后的交流和收到的 OAC 的病人被屏蔽。合成主要端点是 1 年的所有原因死亡,重新梗塞,或分析注册了 642 个病人包括的严重 bleeding.ResultsThe 期末考试有 OAC 和 clopidogrel (双治疗) 的 62 个病人(9.7%) ,和有阿司匹林, OAC 和 clopidogrel (三倍的治疗) 的联合的 580 个病人(90.3%) 。三倍的治疗上的病人更经常是女性的并且是更可能的有 comorbidities。关于在与三倍的治疗病人一起的双治疗之间的主要结束点没有重要差别[17.74% 对 17.24% ;unadjusted 危险比率(HR ) :1.035;95% 信心间隔(CI ) :0.556-1.929;调整 HR:1.026;95% CI:0.544-1.937 ] 。然而,重新梗塞率比三倍的治疗病人在双治疗是显著地更高的(14.52% 对 5.34% ;unadjusted HR:2.807;95% CI:1.329-5.928;调整 HR:2.333;95% CI:1.078-5.047 ) 。另外,在所有原因死亡和严重 bleeding.ConclusionsIn 的二政体之间没有差别有交流后面的一种总线标准并且与 OAC 的一个指示的真实病人,三倍的治疗没与双治疗相比与不利结果的增加的率被联系。而且,它减少了重新梗塞冒险并且没增加严重流血的风险。 | Yan YAN Xiao WANG Jing-Yao FAN Shao-Ping NIE SerGio Raooseiras-Roubin Emad Abu-Assi Jose P Simao Henriques: Fabrizio D'Ascenzo Jorge Saucedo Jose R Gonzalez-Juanate Stephen B Wilton Wouter J Kikkert Ivan Nunez-Gil Albert Ariza-Sole Xian-Tao SONG Dimitrios Alexopoulos Christoph Liebetrau Tetsuma Kawaji Claudio Morettil Zenon Huczek Toshiharu Fujii Luis cL Correia Masa-aki Kawashiri Sasko Kedev | 2017 | Journal of Geriatric Cardiology2017，14，11： | 6 |
| 2 | Volumetric Changes after 90 Y Radioembolization for Hepatocellular Carcinoma in Cirrhosis: An Option to Portal Vein Embolization in a Preoperative Setting?显示文摘 | Julien Edeline Laurence Lenoir Karim Boudjema Yan Rolland Anne Boulic Fanny Le Du Marc Pracht Jean-Luc Raoul Bruno Clément Etienne Garin Eveline Boucher | 2013 | Annals of Surgical Oncology2013，，8： | 3 |
| 3 | Biomarkers of aging显示文摘Aging biomarkers are a combination of biological parameters to(i)assess age-related changes,(ii)track the physiological aging process,and(iii)predict the transition into a pathological status.Although a broad spectrum of aging biomarkers has been developed,their potential uses and limitations remain poorly characterized.An immediate goal of biomarkers is to help us answer the following three fundamental questions in aging research:How old are we?Why do we get old?And how can we age slower?This review aims to address this need.Here,we summarize our current knowledge of biomarkers developed for cellular,organ,and organismal levels of aging,comprising six pillars:physiological characteristics,medical imaging,histological features,cellular alterations,molecular changes,and secretory factors.To fulfill all these requisites,we propose that aging biomarkers should qualify for being specific,systemic,and clinically relevant. | Aging Biomarker Consortium Hainan Bao Jiani Cao Mengting Chen Min Chen Wei Chen Xiao Chen Yanhao Chen Yu Chen Yutian Chen Zhiyang Chen Jagadish K Chhetri Yingjie Ding Junlin Feng Jun Guo Mengmeng Guo Chuting He Yujuan Jia Haiping Jiang Ying Jing Dingfeng Li Jiaming Li Jingyi Li Qinhao Liang Rui Liang Feng Liu Xiaoqian Liu Zuojun Liu Oscar Junhong Luo Jianwei Lv Jingyi Ma Kehang Mao Jiawei Nie Xinhua Qiao Xinpei Sun Xiaoqiang Tang Jianfang Wang Qiaoran Wang Siyuan Wang Xuan Wang Yaning Wang Yuhan Wang Rimo Wu Kai Xia Fu-Hui Xiao Lingyan Xu Yingying Xu Haoteng Yan Liang Yang Ruici Yang Yuanxin Yang Yilin Ying Le Zhang Weiwei Zhang Wenwan Zhang Xing Zhang Zhuo Zhang Min Zhou Rui Zhou Qingchen Zhu Zhengmao Zhu Feng Cao Zhongwei Cao Piu Chan Chang Chen Guobing Chen Hou-Zao Chen Jun Chen Weimin Ci Bi-Sen Ding Qiurong Ding Feng Gao Jing-Dong JHan Kai Huang Zhenyu Ju Qing-Peng Kong Ji Li Jian Li Xin Li Baohua Liu Feng Liu Lin Liu Qiang Liu Qiang Liu Xingguo Liu Yong Liu Xianghang Luo Shuai Ma Xinran Ma Zhiyong Mao Jing Nie Yaojin Peng Jing Qu Jie Ren Ruibao Ren Moshi Song Zhou Songyang Yi Eve Sun Yu Sun Mei Tian Shusen Wang Si Wang Xia Wang Xiaoning Wang Yan-Jiang Wang Yunfang Wang Catherine CL Wong Andy Peng Xiang Yichuan Xiao Zhengwei Xie Daichao Xu Jing Ye Rui Yue Cuntai Zhang Hongbo Zhang Liang Zhang Weiqi Zhang Yong Zhang Yun-Wu Zhang Zhuohua Zhang Tongbiao Zhao Yuzheng Zhao Dahai Zhu Weiguo Zou Gang Pei Guang-Hui Liu | 2023 | Science China(Life Sciences)2023，66，5： | 2 |
| 4 | Purification and characterization of an extcacellular β-glucosidase II with high hydrolysis and transglucosylation activities from Aspergillusniger显示文摘 | Yan TR Lin CL Lin YH | 1998 | Journat of Agricultural and Food Chemistry1998，46，2： | 1 |
| 5 | Using stroke removal to investigate Chi-nese character identification during reading: evidence from eye move-ments显示文摘 | Yan GL Bai XJ Zang CL | 2012 | Read Writ2012，25，5： | 1 |
| 6 | A novel eonnexin 50 (GJA8) mutation in a Chinese family with a dominant congenital pulverulent nuclear cataract 显示文摘 | Yan M Xiong CL Zheng F | 2008 | Molecular Vision2008，4，14： | 1 |
| 7 | Metallo-beta-lactamase-producing Enterobacteriaceae isolates in a university hospital in Taiwan:prevalence of IMP-8 in Enterobacter cloacae and first identification of VIM-2 in Citrobacter freundii显示文摘 | Yan JJ Ko WC Chuang CL | | 0，，04： | 1 |
| 8 | Study on Qianling Lake restoration with artificial wetland显示文摘 | AO ZQ PENG SS YAN CL | 2009 | Agricultural Science & Technology2009，10，15： | 1 |
| 9 | Effects ofmotilin in the paraventricular hopothalamic nucleus on gastric motility 显示文摘 | Yan CL Wang SB Jiang ZY | 2002 | applied physiology of China journal2002，18，： | 1 |
| 10 | Study on Qianling Lake restoration with artificial wetland显示文摘 | AO ZQ PENG SS YAN CL | 2009 | Agricultural Science & Technology2009，10，15： | 1 |
| 11 | Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis 显示文摘 | Chen YS Yan W Geczy CL | 2009 | Arthritis Res Ther2009，11，2： | 1 |
| 12 | Control of PERK eIF2kinase activity by the endoplasmic reticulum stress-induced molecular chaperone p58IPK显示文摘 | Yan W Frank CL Korth MJ | 2002 | Proc Natl Acad Sci USA2002，99，15： | 1 |
| 13 | Design, preparation and characterization of cyclic RGD dimer for targeting integrin Cv133 显示文摘 | Zhang L Zhang CL Yan P | 2011 | JCIT2011，6，12： | 1 |
| 14 | Study on Qianling Lake restoration with artificial wetland 显示文摘 | AO ZQ PENG SS YAN CL | 2009 | Agricultural Science & Technology2009，10，15： | 1 |
| 15 | Effect of different pres- sure schedule on + Gz protection afforded by an extended cov- erage anti-G suit显示文摘 | Geng XC Zhau CL Yan GD | 1999 | Safe J1999，29，2： | 1 |
| 16 | Centrifuge assessment of the + Gz protection afforded by pressure breathing for + Gz (PBG) with different pressure schedules 显示文摘 | Geng XC Zhan CL Yan GD | 2000 | Safe J2000，30，1： | 1 |
| 17 | An engineered Bacillus thuringiensis strain with insecticidal activity against Scarabaeidae(Anomala corpulenta)and Chrysomelidae(Leptinotarsa decemlineata and Colaphellus bowringi)显示文摘 | Yan GX Song FP Shu CL | | 0，，05： | 1 |
| 18 | Determinants of sui cidal ideation in gynecological cancer patients显示文摘 | Tang GX Yan PP Yan CL | 2016 | Psy- chooncology2016，25，1： | 1 |
| 19 | Fractional 1320 nm Nd : YAG laser in the treatment of ache vulgaris: a pilot study显示文摘 | Deng H Yuan DF Yan CL | 2009 | Photodermatol Photoimmunol Photomed2009，25，： | 1 |
| 20 | Metallo-beta-lactamase- producing Enterobacteriaceae isolates in a university hospital in Taiwan: prevalence of IMP-8 in Enterobacter cloacae and first identification of VIM-2 in Citrobacter freundii显示文摘 | Yan J J Ko WC Chuang CL | 2002 | J Antimicrob Chemother2002，50，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员